TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: 3-Month Complete Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle Carnitine Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Influenza antibody titre
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neurofeedback success (brain activation difference)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain points of muscle and articulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Peak value of surgically induced C-reactive protein (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: scores on Maslach Burnout Inventory-General Survey (MBI-GS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Platelet inhibitory effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Jankovic Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of TS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients with Confirmed Partial Response or Better
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical markers of oxidative stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score on a migraine pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of MDRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes of VFT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes of CGI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes of SCAG
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes of MMSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensitivity in identifying significant colonic polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Facial expression recognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to release of radiolabel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mucosal Permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time to first rescue analgesic demand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and percentage of potential cases and controls found eligible for the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number and percentage of cases and controls who sign informed consent
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number and percentage of cases and controls who complete each part of the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Median glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Foot lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Participants With Solicited Local and Systemic Adverse Events for 7 Days After Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Unsolicited Adverse Events for 28 Days After Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Diffusing Capacity of the Lungs for carbon monoxide (DLCO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Quality of Life Questionnaire measured with the Spinal Cord Injury - Quality of Life (SCI-QOL) items relevant to bowel management
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Ambulatory blood pressure and heart rate monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Anorectal Manometry (ARM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Alteration of the cellular arterial gradient of CO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Preterm Birth
Endpoint domain: Mortality/survival
Primary endpoint: Implant mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biopsy proven acute rejection episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in inflammation marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Consonant-Nucleus-Consonant (CNC) Words Scores Over Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Arizona Biomedical Institute (AzBio) Sentences in Quiet Scores Over Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in AzBio Sentences in Noise Scores (S0N0) Over Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamilton Rating Scales of Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants Who Think About the Harm of Smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants Whose First Cigarette After Waking is 30 Mins or Less
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Plan to Quit Smoking
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Occurrence of skin cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Surgical Pleth Index (SPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: humoral rejection diagnosed by biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: permanent resumption of dialysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Diagnostic rate of patients with polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-free survival at 12 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of penetration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Frequency of maintained erection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Reduction in the peak deep body temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary artery/stent patency rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Serum tranexamic acid concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median Interval Change From Baseline in Peak VO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median Interval Change From Baseline in the Minute Ventilation and Carbon Dioxide Production (VE/VCO2 Slope)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Concentration Maximum (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients discontinued due to tolerability issues
Endpoint domain: Adverse events/effects
Primary endpoint: Lipoprotein particles concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: lipoprotein particles size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Trimethylamine-N-oxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Brain Scans without Amyloid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ADL Scores (Activities of Daily Living)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: RSH Scores (Return to Previous Health)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EDSS (Expanded Disability Status Scale) Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in exhaled Nitric Oxide concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Presence / absence of stains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absence of a major territorial stroke or death
Endpoint domain: Mortality/survival
Primary endpoint: Complete aneurysm occlusion (Raymond 1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction in Size of All Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Histological Grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Adherence to Anti-Retroviral Medications Questionnaire
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: ability to adequately visualize the operative field
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: completion of planned surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of patients with Patient Benefit Index (PBI-S) ≥ 1
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HIV RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Muscle strength (torque)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in CogState One-back subtest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Concordance in Left Ventricular Ejection Fraction measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Concordance in E' wave measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Concordance in stroke volume measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety assessment of the drug
Endpoint domain: Adverse events/effects
Primary endpoint: Airway driving pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Diagnostic and prognostic value of biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Participants Achieving Physician's Global Assessment (PGA) Response of Clear or Almost Clear
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of Percent Change in Forced Vital Capacity (FVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of Range Of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Serum levels of Osteocalcin and CTX
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Kmean (Spherical refractive power of central cornea)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AST (Anterior central corneal astigmatism)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AL (Axial length)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimal Biologic Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of adverse events experienced by patients
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Glucose Variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change(s) in Behavior and/or Concerns of Diabetics
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Smoking Urge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-tonsillectomy bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical and laboratory data analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to treatment re-entry
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pharmacokinetics of GSK573719
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean differences in adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of participants with lifeline wireless phones
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of participants with limited wireless minutes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of participants with unlimited wireless minutes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 2-year survival proportion
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants Who Achieved a Birmingham Vasculitis Activity Score for Wegener's Granulomatosis (BVAS/WG) Score of 0 and Successfully Completed Prednisone Taper at 6 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in HgBA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline of ventricular repolarization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: survival in patients with secondary rupture aneurysm
Endpoint domain: Mortality/survival
Primary endpoint: Rates of engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Event related potentials (P50, P300, N100)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Measures of standard cognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Measures of social cognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of subjects having abnormal hematology laboratory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: PTS Assessment Completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in prevalence of malaria RDT positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Efficacy of common bile duct stone clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Score on Modified MDRS Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ADHD core symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the number of reports made to Child Protective Services (CPS)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in the compliance with American Academy of Pediatrics guidelines for evaluation of suspected abuse in patients <2 years of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic lower extremity valgus angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to cessation of vasopressor use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Meibomian Gland Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stage of change
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Mean Change from Baseline in WOMAC Pain Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of the Median Factor VIII (FVIII) Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of CD133+ Polymorphonuclear cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adequate Relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Study Retention Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Safety of DTacP-IPV//PRP~T combined vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Change in smoking prevalence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Operator dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for Pazopanib Versus Sunitinib
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients free from pulmonary exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of reocclusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Physician communication
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Reduction of toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Levels of purine in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Level of cxcl13 in SLE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: In-breast local failure
Endpoint domain: Mortality/survival
Primary endpoint: Functional changes in the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Structural changes in the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Target Lesion Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Abdominal Diastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Symptoms and side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Time to breathing room air
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Level of Endotoxin in blood samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change of Endotoxin from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Safety of single procedure PVI + PWI
Endpoint domain: Adverse events/effects
Primary endpoint: 28-Day Mortality Rate
Endpoint domain: Mortality/survival
Primary endpoint: Small-Bowel mucosal morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC) of CLS003
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Plasma Concentration (Cmax) of CLS003
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of early discontinuation of empiric antifungal therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Consecutive Weeks of Marijuana Abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Point Prevalence Abstinence Post Treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proptosis response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity of the experimental DualDur in Vitro Diagnostic System
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specificity of the experimental DualDur In Vitro Diagnostic System
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDD section of Mood Disorders Module of Structured Clinical Interview for DSM-IV (SCID)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean speed of wound closure (MSWC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duke Social Support Index
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Number of Participants Reporting Fever
Endpoint domain: Adverse events/effects
Primary endpoint: Complete Response (CR) and Partial Response (PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of Subjects With Injection Site Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Change in 2-Item Warmth Perception Measure (feet)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants With Lidocaine Ineffectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Biopsy Proven Acute Rejection (BPAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of bleeding and spotting days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progestin effects on endometrial histology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ovulation (Yes/no)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in KCCQ Physical Limitation Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fortimel® compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Investigator Satisfaction With Implants
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participant Satisfaction With Implants
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status